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Edited by Guido TettamantiAbstract The eﬀects of a mammalian cyclic antimicrobial
peptide, rhesus theta defensin 1 (RTD-1) and its open chain
analogue (oRTD-1), on the phase behaviour and structure of
model membrane systems (dipalmitoyl phosphatidylcholine,
DPPC and dipalmitoyl phosphatidylglycerol, DPPG) were
studied. The increased selectivity of RTD-1 for anionic DPPG
over zwitterionic DPPC was shown by diﬀerential scanning
calorimetry. RTD-1, at a molar peptide–lipid ratio of 1:100,
induced considerable changes in the phase behaviour of DPPG,
but not of DPPC. The main transition temperature, Tm, was
unchanged, but additional phase transitions appeared above Tm.
oRTD-1 induced similar eﬀects. However, the eﬀects were not
observable below a peptide:lipid molar ratio of 1:50, which
correlates with the weaker biological activity of oRTD-1. Small-
and wide-angle X-ray scattering revealed for DPPG the
appearance of additional structural features induced by RTD-1
above Tm, which were interpreted as correlated lamellar struc-
tures, with increased order of the fatty acyl side chains of the
lipid. It is proposed that after initial electrostatic interaction of
the cationic rim of the peptide with the anionic DPPG
headgroups, leading to stabilized lipid–peptide clusters, the
hydrophobic face of the peptide assists in its interaction with
the fatty acyl side chains eventually leading to membrane
disruption.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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scattering1. Introduction
Mammalian defensins play an important role in innate im-
munity [1] and like other antimicrobial peptides they may serve
in future as substitutes for conventional antibiotics, a prospect* Corresponding author. Fax: +43-316-4120-390.
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DPPG, dipalmitoyl-sn-glycero-3-[phospho-rac-(l-glycerol)] (Na-salt);
DSC, diﬀerential scanning calorimetry; PBS, phosphate buﬀered
saline; SAXS, small-angle X-ray scattering; WAXS, wide-angle
X-ray scattering
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doi:10.1016/j.febslet.2004.03.112which becomes increasingly important considering the growing
problems associated with microbial resistance against antibi-
otics [2].
One conceivable mechanism of action of such antimicrobial
peptides is the perturbation of the integrity of bacterial
membranes, eventually leading to loss of plasma membrane
function, e.g. by lysis [3]. Two general mechanisms have been
discussed, the barrel-stave mechanism in which the peptides
integrate into the membrane to form a toroidal pore [4] and the
carpet mechanism, in which peptides assemble at the head-
group region of the bilayer and act in a detergent-like fashion
to disrupt the membrane [5]. These are probably not the only
feasible mechanisms. Others include the induction of lipid
unmixing, which will eventually lead to defunctionalization of
the membrane, or the formation of non-bilayer structures,
such as cubic phases [6]. Penetration of the bilayer and some
direct action upon binding of an intracellular target have also
been discussed [7,8].
Over the years it has turned out that an important issue with
respect to the usability of peptide antibiotics is that they
should exhibit high selectivity for (negatively charged) bacte-
rial membranes, to avoid toxicity against mammalian cells,
while preserving eﬃcient bactericidal properties. Many natural
antimicrobial peptides are therefore cationic, and their mech-
anism of action is presumed to involve initial binding due to
electrostatic interaction, followed by perturbation of the nor-
mal phase behaviour of the plasma membrane [9]. As biolog-
ical membranes are apparently designed to be in a state close
to a phase transition at the environmental conditions the or-
ganism normally encounters [10–12], even slight shifts in phase
behaviour may impart membrane properties such as to seri-
ously aﬀect cell viability.
Considering the wide variety of peptides exhibiting antimi-
crobial properties, no consensus mechanism can be expected.
Moreover, in most cases the mode of action on bacterial
membranes is largely unknown.
Defensins are small cysteine-rich antimicrobial peptides. The
a- and b-defensins are the predominant defensin subfamilies,
which are also expressed in primates and humans. The h-de-
fensins, which have been found in rhesus macaque leukocytes
[13], are unusual as they have a circularized peptide chain de-
rived from two precursor defensins, which themselves show high
sequence homology to a-defensins. The two strands of their
antiparallel b-sheet are linked by three disulﬁde bonds to give a
boat-like structure with a charged face and a hydrophobic face
that exposes the cystine side chains [14].blished by Elsevier B.V. All rights reserved.
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bial peptide, rhesus theta defensin 1 (RTD-1) (Sequence
GFCRCLCRRGVCRCICTR), and its open chain analogue
(oRTD-1) [13], on the phase behaviour of two membrane
mimetic systems, i.e., liposomes consisting of dipalmitoyl-
phosphatidylcholine (DPPC; dipalmitoyl-sn-glycero-3-phos-
phocholine) and dipalmitoyl-phosphatidylglycerol (DPPG;
dipalmitoyl-sn-glycero-3-[phospho-rac-(l-glycerol)] (Na-salt)),
representative lipids for mammalian and bacterial plasma
membranes, respectively.2. Materials and methods
Phospholipids, DPPC and DPPG, were obtained from Avanti Polar
Lipids (Alabaster, AL, USA) and used without further puriﬁcation
(>99%). All other chemicals were of analytical grade and from Sigma
or Merck (both Vienna, Austria). Before and after calorimetric and X-
ray measurements, the purity of both phospholipids was checked by
thin layer chromatography to exclude degradation. CHCl3/CH3OH/
NH3;conc (75:25:6, v:v:v) was used as a solvent and aluminium sheets,
silica gel 60, purchased from Merck (Darmstadt, Germany), were used
as stationary phase.
2.1. Synthesis of RTD-1 and oRTD-1
RTD-1 and oRTD-1 were synthesized using BOC chemistry [15].
Formation of the disulﬁde bonds was achieved by air oxidation
overnight. For RTD-1, the oxidized peptide was cyclized as described
in [14]. Purity was conﬁrmed by HPLC and mass spectrometric
analysis.
2.2. Preparation of multilamellar and unilamellar liposomes
Lipids were dissolved in chloroform and deposited as a ﬁlm on the
inside of a test tube by evaporation under a stream of nitrogen. After
drying overnight in vacuum, the ﬁlms were suspended in phosphate
buﬀered saline (PBS, 20 mM Na-phosphate, 130 mM NaCl, pH¼ 7.4)
and hydrated under intermittent vortexing over 4 h at 50 C for DPPC,
or incubated at 65 C and vortexed at 5,10, 20, 30, 60 and 90 min for 1
min for DPPG (this procedure yields large unilamellar liposomes) [16].
Peptides were added at the appropriate concentrations to the hydrating
buﬀer.Fig. 1. Excess heat capacity function of the interaction of RTD-1 and oRTD
(heating scans), in PBS. For clarity, the curves have been separated by increm
the main graphs the main transition part.2.3. Diﬀerential scanning calorimetry
Diﬀerential scanning calorimetry (DSC) experiments were per-
formed in a Microcal VP-DSC scanning microcalorimeter (North-
ampton, MA, USA), at a lipid concentration of 1 mg/ml in PBS.
Peptides were present at the indicated molar peptide:lipid ratios.
Heating and cooling scans were performed between 20 and 50 C for
DPPC and 10–60 C for DPPG, at a scan rate of 30 C/h and prescan
thermal equilibration of 10 and 20 min, respectively.
2.4. Small-angle and wide-angle X-ray scattering
Small-angle and wide-angle X-ray scattering (SAXS, WAXS) ex-
periments were performed on a modiﬁed Kratky compact camera
(SWAX, Hecus X-ray Systems, Graz, Austria) allowing simultaneous
recording of diﬀraction data in the small-angle and wide-angle region
[17]. Ni-ﬁltered CuKa-radiation was used (k ¼ 1:542 A) at 4 kW
power, originating from a rotating-anode X-ray generator (Rigaku-
Denki, Japan). The camera was equipped with a Peltier-controlled
thermostatted sample stage (temperature resolution 0.1 C) and two
linear position-sensitive detectors. Angular calibration in the small-
angle region was obtained using silver stearate, in the wide-angle
region p-Br benzoic acid was used. Temperature control and data ac-
quisition were achieved by a programmable temperature and time
controller (MTC 2.0, Hecus X-Ray Systems, Graz, Austria). After
equilibration of the samples to the respective temperature for 1000 s
(2000 s for downscans), data were recorded for 9000 s at each tem-
perature, allowing for 7200 s in the small-angle region and 1800 s in the
wide-angle region.3. Results
3.1. Selectivity of RTD peptides towards zwitterionic (DPPC)
and anionic (DPPG) lipids
In zwitterionic DPPC liposomes, both RTD-1 and oRTD-1
at a peptide:lipid molar ratio of 1:25 had minimal eﬀect on the
chain melting or main transition temperature Tm (for DPPC
the temperature of the transition between lamellar gel, Pb0 , and
liquid crystalline phase, La) at around 41 C (Fig. 1A). A slight
increase was observed in the temperature of the pretransition
(lamellar tilted gel, Lb0 , to the ripple phase, Pb0 ) at about 34 C,
for RTD-1, indicating a slight stabilization of the Lb0 over the-1 with (A) DPPC and (B) DPPG at a peptide:lipid molar ratio of 1:25
enting Cp. The insets show the pretransition part of the thermograms,
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(indicated by the increase in half-width) of the pretransition,
resulting in a very ﬂat wide peak.
Interaction of the peptides with anionic DPPG resulted in
signiﬁcant changes (Fig. 1B). Although Tm again remained
unchanged within experimental error at around 40 C, two
additional thermotropic phase transitions were observed for
oRTD-1, at about 41–42 C, and up to ﬁve for RTD-1, in the
range between 41 and 45 C. The enthalpy of themain transition
was reduced in the presence of peptide, however, post-main
transition enthalpies make up for the diﬀerence. This indicates
that all lipid molecules eventually melt, including those engaged
in interaction with peptide. Pretransition temperatures did not
vary appreciably, and cooperativity was notably decreased for
RTD-1, and less pronouncedly for oRTD-1.
It should be noted that the cooling scans did not show
transitions above Tm, most likely due to kinetic hindrance of
subdomain formation. However, there were weak additionalFig. 2. Excess heat capacity function of DPPG with (A) RTD-1 at peptide:li
(heating scans), in PBS. For clarity the curves have been displaced by increme
the main graphs the main transition region. (C) Cooling scans of RTD-1 astransitions observable below Tm (Fig. 2C), for the peptide:lipid
molar ratio of 1:25 the additional transitions have merged with
the main transition peak, leading to a widening of this peak.
3.2. Sensitivity of DPPG model membranes towards RTD-1 and
oRTD-1
To investigate the molecular reason for the reported diﬀerent
antibacterial activity we checked the sensitivity of DPPG to-
wards RTD-1 and oRTD-1 by using the peptides at diﬀerent
peptide:lipid molar ratios. RTD-1 still showed a notable ad-
ditional transition above Tm at a peptide:lipid molar ratio of
1:100, at around 42 C (Fig. 2A); when induced by oRTD-1,
this transition vanished at peptide:lipid molar ratios above
1:50. Also, for both peptides, DHm decreased with increasing
peptide concentrations, which is indicative of lipids associating
with peptides, resulting in the inability of the lipids to partic-
ipate in the main transition and to contribute to the melting
enthalpy.pid molar ratios of 1:25, 1:50 and 1:100. (B) oRTD-1 at 1:25 and 1:50
nting Cp. The insets show the pretransition region of the thermograms,
in panel A (data smoothed for clarity).
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DPPG liposomes
To ﬁnd out more about the mechanism of the interaction of
RTD-1 with DPPG we studied the structural eﬀects of the
peptides on DPPG liposomes. At NaCl concentrations of up to
150 mM, DPPG forms large unilamellar vesicles after prepa-
ration according to the protocol given in 2.1 [16]. Indeed, at 20
C such vesicles could also be observed in the presence of
RTD-1 (peptide:lipid molar ratio of 1:25), characterized by
diﬀuse scattering which exhibited a rather broad side maxi-
mum at q ¼ 0:105 A1 (Fig. 3A). Wide-angle scattering data
showed abroad reﬂection around q ¼ 1:5 A1 (Fig. 3B) in-
dicative of local order in the packing of the DPPG hydrocar-
bon chains. With increasing temperature the smooth shape of
the side maximum (SAXS) became partially superimposed by
two (ﬁrst order) Bragg reﬂections at q ¼ 0:0927 A1 (d ¼ 67:8
A) and 0.127 A1 (d ¼ 49:5 A), respectively, which were most
pronounced at T ¼ 43 C and disappeared again when the
sample was heated to T ¼ 50 C. Additional weak peaks be-
came visible at q ¼ 0:251 A1 (d ¼ 25:0 A) and 0.382 A1
(d ¼ 16:4 A), which are the second order reﬂections (not
shown). Concomitantly, the wide-angle peak at around
d ¼ 1:50 A1 (d ¼ 4:20 A) became sharper with the appear-
ance of the SAXS Bragg reﬂections, indicating increased
packing order of the DPPG hydrocarbon chains, and disap-
peared only at T ¼ 50 C, while pure DPPG showed this peak
only below 40 C (not shown). Upon cooling, the Bragg re-
ﬂections did not reappear, consistent with the observations byFig. 3. SAXS (A,C) and WAXS (B,D) diﬀractograms of DPPG, in the p
peptide:lipid ratio of 1:25. Scattering intensity is plotted versus q (q ¼ 4p=kDSC. The SAXS scattering is consistent with the formation of
mixed lamellar phases, which is also corroborated by the ap-
pearance of WAXS reﬂections.
For oRTD-1, similar eﬀects were found (Fig. 3C and D),
however, the wide-angle reﬂection at 1.50 A1 is much weaker,
indicating less eﬃcient chain-packing. This peak completely
disappears above 41 C, corresponding to the disappearance of
the weak SAXS Bragg reﬂection above 41 C. Interestingly, at
50 C a new SAXS Bragg peak at 0.105 A1 (d ¼ 59:8 A)
appears, indicating a new correlated lamellar ﬂuid phase (ev-
ident by the lack of a wide-angle reﬂection).4. Discussion
Investigation of the inﬂuence of RTD-1 and oRTD-1 on the
phase behaviour of zwitterionic DPPC and anionic DPPG
liposomes corroborated the reported selectivity for (negatively
charged) bacterial membranes. The peptides were not able to
notably alter the phase transition properties of DPPC. How-
ever, in DPPG the peptides, in particular RTD-1, induced the
formation of additional phases. A possible explanation for the
observed phase transitions at temperatures above Tm is that
lipids engage with the peptides in the formation of small do-
mains that are stabilized by electrostatic and hydrophobic in-
teractions. The phase separation induced by this process can
be the trigger for loss of membrane integrity, and thus explain
the bactericidal activity of the peptides. This is corroboratedresence of RTD-1 (A,B) and in the presence of oRTD-1 (C,D) at a
sin h; magnitude of the scattering vector).
Fig. 4. (A) Surface representations of RTD-1 showing the distribution
of positive (dark grey), polar (T17), hydrophobic (light grey) and
cysteine residues (medium grey) for a typical structure from the en-
semble of NMR-derived structures. Note that the family of NMR
structures of RTD-1 suggests a degree of ﬂexibility characterized by
bending motions about the plane containing the elongated cyclic
backbone, but also slight torsion. Individual structures show vari-
ability in the precise positioning of the amino acid side chains, but the
trend of one charged face and one face dominated by the disulﬁde
bonds is common to all structures. The two surface representations are
rotated 180 with respect to one another. (B,C) Models of RTD-1 (B)
and oRTD-1 (C) showing the peptide backbone and the disulﬁde
bonds. The terminal charges in oRTD-1 are indicated by + and ), the
residues are coloured as in A.
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downscans, which ‘freeze’ below Tm (Fig. 2C).
SAXS diﬀraction parallels the DSC results, as at tempera-
tures above the main transition additional structural features
appear, which may be interpreted as correlated lamellar
structures induced by the peptide. The lipid ordering eﬀect at
T > Tm is also reﬂected in increased side chain ordering ob-
served in the wide-angle pattern in the presence of RTD-1,
which corroborates this notion. The appearance of a SAXS
Bragg peak at 50 C in presence of oRTD-1, corresponding to
a correlated, ﬂuid lamellar phase, is probably a consequence of
the additional charge at the open ring ends of oRTD-1, which
aids in shielding the charges of DPPG, thus permitting corre-
lation of the bilayers. The superiority of RTD-1 over oRTD-1
in its bactericidal activity was reﬂected by the observation that
RTD-1 was able to induce this phase separation at concen-
trations which were only half of those of oRTD-1 required to
have the same eﬀect. Moreover, the observation that oRTD-1
leads to less eﬃcient hydrocarbon chain packing as evident
from WAXS reﬂections (Fig. 3D) than RTD-1 (Fig. 3B),
which completely disappear above 41 C, conﬁrms the reduced
ability of oRTD-1 to form stabilized domains.
With its unique circular peptide backbone and three disul-
ﬁde bonds, RTD-1 exhibits a structure that is novel among
antimicrobial peptides. Recent NMR studies [14] showed that
despite the conformational restrictions imposed by its head-to-
tail cyclized backbone and the laddered disulﬁde bonds RTD-1
exhibits a speciﬁc type of internal ﬂexibility. In particular, the
turns on both ends of the elongated b-sheet region are very
well deﬁned but are involved in a hinge-like motion with re-
spect to the b-sheet part of the molecule [14].
Many open chain peptides display a random structure in
solution and only adopt the secondary structure of the active
form upon interaction with the membrane. One prominent
example of this behaviour is PGLa [18], a 21-residue cationic
peptide from the skin of the South African frog Xenopus laevis.
In contrast, RTD-1 is expected to show a similar structure
both in solution and in contact with membranes, due to the
structural restriction mentioned above. However, the mobility
of the molecule may assist in directing the positively charged
arginine side chains, which, in aqueous solution, are almost
evenly distributed over the surface of RTD-1 (Fig. 4), towards
one face of the molecule, while exposing the disulﬁde bonds
and hydrophobic side-chains on the other face. It is therefore
conceivable that the positively charged Arg side chains initially
interact with the negatively charged DPPG headgroups, re-
sulting in stabilized lipid–peptide clusters. This proposal is
consistent with recent ﬁndings by Weiss et al. [19], who noted
that RTD-1 shows two physically distinct bound states in lipid
bilayers. In one state RTD-1 is oriented with its backbone ring
parallel to the bilayer plane, corresponding to the initial stage
of electrostatic interaction described above. The second state
could not be fully deﬁned by Weiss et al., but it seems to be
diﬀerent from both the initial and the so-called I state known
from other antimicrobial peptides [19]. It seems likely that the
hydrophobic face of the peptide would interact with the hy-
drocarbon chains of the phospholipid, which may eventually
lead to voids in the hydrophobic core and consequential
membrane disruption.
Although the exact mode of interaction and the nature of the
antimicrobial activity of RTD-1 is still unknown it is inter-
esting to note that the positive charges in RTD-1 are associ-ated with Arg residues rather than Lys residues. Arg residues
contain a substantially hydrophobic side chain and on average
score more highly on hydrophobicity scales than Lys residues
[20].
NMR studies have shown that RTD-1 and oRTD-1 have
similar solution structures as well as a comparable degree of
ﬂexibility [14]. Therefore, the reduced biological activity of
oRTD-1 may reﬂect the charge re-distribution created by the
306 P.M. Abuja et al. / FEBS Letters 566 (2004) 301–306introduction of a negative charge at the C-terminus, rather
than a structural or motional diﬀerence between the two
peptides – the charged C-terminus might, for instance, reduce
the membrane insertion of oRTD-1.
In summary we have demonstrated that both RTD-1 and
oRTD-1 show high selectivity for anionic DPPG over zwit-
terionic DPPC. In spite of the identical amino acid sequence
and of the very similar tertiary structure, the activity of RTD-1
towards DPPG is signiﬁcantly higher. This illustrates one of
the inherent diﬃculties of understanding the mechanism of
antimicrobial peptide action: apparently minimal diﬀerences
may have signiﬁcant consequences.
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